DDAP Assessing Changes to Confidentiality Under Act 33

DDAP Assessing Changes to Confidentiality Under Act 33

On July 7, 2022, Gov. Wolf signed Act 33 of 2022, which amends Act 63 of 1972 as it pertains to confidentiality of substance use disorder patient records. Act 33 incorporates federal confidential protections under the Health Insurance Portability and Accountability Act (HIPAA) and 42 CFR Part 2. Act 33, which took effect immediately, prohibits the Pennsylvania Department of Drug and Alcohol Programs (DDAP) from promulgating or enforcing a regulation that restricts any disclosure of records or information that is permitted by Act 33. DDAP is currently reviewing Act 33 to determine next steps as a regulatory agency and will be providing additional information and details on the DDAP website in the near future.